Drug · DIN 02469898
ADMELOG
3 ML CARTRIDGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 22, 2019; first marketed November 22, 2019.
- Drug Identification Number (DIN)
- 02469898
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin lispro A10AB04
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN LISPRO | 100 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 16, 2017: NOC 20050New Drug Submission (NDS)
Other DINs named ADMELOG
- DIN 02469901 · Marketed